Skip to main content
Figure 3 | BMC Infectious Diseases

Figure 3

From: Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials

Figure 3

Meta-analysis of microbiological treatment success comparing ertapenem with piperacillin/tazobactam for complicated infections treatment at test-of-cure visit. The analysis based on microbiologically evaluable population. Vertical line indicates no difference between ertapenem and piperacillin/tazobactam. The size of each square denotes the proportion of information given by each trial.

Back to article page